|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/5575 | |
| A61P 27/02 | |||
| A61L 2/20 | |||
| A61K 9/08 |
| (11) | Number of the document | 1825855 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05814731.5 |
| Date of filing the European patent application | 2005-12-09 | |
| (97) | Date of publication of the European application | 2007-08-29 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2005/022618 |
| Date | 2005-12-09 |
| (87) | Number | WO 2006/062184 |
| Date | 2006-06-15 |
| (30) | Number | Date | Country code |
| 2004356969 | 2004-12-09 | JP |
| (72) |
KADO, Takehiro,, JP
OKAMOTO, Tomoyuki,, JP
ASADA, Hiroyuki,, JP
KIMURA, Akio,, JP
|
| (73) |
SANTEN PHARMACEUTICAL CO., LTD.,
9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka-shi, Osaka 533-8651,
JP
|
| (54) | PRODUCT CONTAINING PROSTAGLANDIN HAVING FLUORINE ATOM IN MOLECULE |
| PRODUCT CONTAINING PROSTAGLANDIN HAVING FLUORINE ATOM IN MOLECULE |